Novo Nordisk’s next-gen obesity drug results a letdown for investors
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
CHICAGO — Novo Nordisk’s next-generation obesity injection targeting the amylin hormone showed substantial weight loss in an early study, but ...
A Merck drug developed to prevent disease from respiratory syncytial virus (RSV) in infants has won FDA approval, introducing competition ...
Yearly change (95% CI) on the HDDMS, cUHDRS, and cUHDRS components by CAG category. Credit: Brain (2025). DOI: 10.1093/brain/awaf127 A ...
by David J. Neal Credit: Unsplash/CC0 Public Domain Three lots of a drug designed to treat various urinary tract infections ...
Scripta Insights, a company that develops pharmacy navigation solutions for self-insured employers, health plans and members, is entering into a ...
Patients with tenosynovial giant cell tumor can take some comfort in knowing that this rare type of tumor affecting joints ...
Astellas Pharma already has the first FDA approval for a therapy that goes after Claudin 18.2, a protein whose overexpression ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses ...
In the life sciences community, there’s a lot of discussion about how artificial intelligence is speeding up drug research, enabling ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.